| | |
No. of isolates resistant to indicated agent at the indicated breakpoint (% resistance)a
| |
|---|
|
S. entericaserovar
|
No. of isolates
|
AMP Ampicillin
|
CAZ Ceftazidime
|
CTX Cefotaxime
|
FEP Cefepime
|
NAL Nalidixic acid
|
CIP Ciprofloxacin
|
SMX Sulfamethoxazole
|
TMP Trimethoprim
|
TCY Tetracycline
|
GEN Gentamicin
|
STR Streptomycin
|
CHL Chloramphenicol
|
MDR
|
|---|
|
Enteritidis
|
257
|
143(55.64)
|
11(4.28)
|
14(5.45)
|
18(7.01)
|
212(82.49)
|
11(4.28)
|
141(54.86)
|
23(89.49)
|
76(29.57)
|
23(8.95)
|
110(42.81)
|
10(3.89)
|
116(45.14)
|
|
Typhimurium
|
523
|
453(86.62)
|
43(82.21)
|
68(13.01)
|
69(13.19)
|
437(83.56)
|
60(11.47)
|
455(86.99)
|
337(64.44)
|
457(87.38)
|
340(65.01)
|
391(74.76)
|
381(72.85)
|
454(86.80)
|
|
1,4,5,12:i:-
|
244
|
220(90.16)
|
18(7.37)
|
30(12.29)
|
29(11.88)
|
182(74.59)
|
28(11.47)
|
220(90.16)
|
128(52.46)
|
228(93.44)
|
141(57.78)
|
164(67.21)
|
164(67.21)
|
218(89.34)
|
|
Stanley
|
167
|
14(8.38)
|
10(5.99)
|
11(6.58)
|
9(5.39)
|
19(11.37)
|
8(4.79)
|
35(20.96)
|
14(8.38)
|
20(11.98)
|
13(7.78)
|
25(14.97)
|
13(7.78)
|
18(10.78)
|
|
Derby
|
46
|
15(26.08)
|
2(4.35)
|
3(6.52)
|
3(6.52)
|
17(36.96)
|
4(8.69)
|
35(76.08)
|
14(30.44)
|
22(47.83)
|
14(30.44)
|
19(41.30)
|
16(34.78)
|
15(32.61)
|
|
Rissen
|
36
|
26(72.22)
|
3(8.33)
|
5(13.89)
|
6(16.67)
|
5(13.89)
|
1(2.78)
|
23(63.89)
|
30(83.33)
|
31(86.11)
|
7(19.44)
|
16(44.44)
|
5(13.89)
|
15(41.67)
|
|
Weltevreden
|
35
|
3(8.57)
|
2(5.71)
|
2(5.71)
|
2(5.71)
|
4(11.43)
|
1(2.86)
|
8(22.86)
|
4(11.43)
|
6(17.14)
|
3(8.57)
|
6(17.14)
|
2(5.71)
|
3(8.57)
|
|
Infantis
|
28
|
23(82.14)
|
0
|
3(10.71)
|
2(7.14)
|
23(82.14)
|
0
|
23(82.14)
|
19(67.86)
|
19(67.86)
|
4(14.28)
|
4(14.28)
|
21(75)
|
21(75)
|
|
Agona
|
24
|
4(16.67)
|
0
|
1(4.17)
|
3(12.5)
|
4(16.67)
|
3(12.5)
|
7(29.17)
|
3(12.5)
|
8(33.33)
|
4(16.67)
|
5(20.83)
|
5(20.83)
|
6(25)
|
|
Albany
|
22
|
21(95.45)
|
3(13.63)
|
4(18.18)
|
4(18.18)
|
20(90.9)
|
1(4.54)
|
22(100)
|
20(90.9)
|
21(95.45)
|
4(18.18)
|
7(31.81)
|
21(95.45)
|
20(90.9)
|
|
Newport
|
19
|
3(15.79)
|
2(10.53)
|
1(5.26)
|
0
|
4(21.05)
|
1(5.26)
|
5(26.31)
|
3(15.79)
|
6(31.57)
|
2(10.53)
|
5(26.31)
|
3(15.79)
|
4(21.05)
|
|
Typhi
|
4
|
1(25)
|
0
|
1(25)
|
0
|
1(25)
|
0
|
1(25)
|
1(25)
|
1(25)
|
1(25)
|
1(25)
|
1(25)
|
1(25)
|
|
Paratyphi (A + B + C)
|
24
|
5(20.83)
|
2(8.33)
|
1(4.16)
|
1(4.16)
|
5(20.83)
|
1(4.16)
|
4(16.66)
|
0
|
2(8.33)
|
1(4.16)
|
4(16.66)
|
0
|
3(12.5)
|
|
Other 114 NTS serovars
|
335
|
106(31.64)
|
28(8.35)
|
32(9.55)
|
23(6.86)
|
119(35.52)
|
23(6.86)
|
141(42.09)
|
106(31.06)
|
161(31.64)
|
54(16.11)
|
121(36.11)
|
72(21.49)
|
103(30.74)
|
|
Total (% resistance)b
| |
1037(58.78)
|
124(7.03)
|
176(9.98)
|
169(9.58)
|
1052(59.64)
|
142(8.05)
|
1120(63.49)
|
702(39.79)
|
1058(59.97)
|
611(34.64)
|
878(49.77)
|
714(40.48)
|
997(56.52)
|
-
aThe percentage means the proportion of MDR isolates within each serotype.
-
bThe percentage means the proportion of MDR isolates in total 1764 isolates.
